CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2018	Mar. 31, 2017
Operating activities
Net income		$ 62,177	$ 80,194
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		63,514	56,975
Amortization of intangible and other assets and favorable/unfavorable leases		881	381
Amortization of long-term prepaid rents		639	493
Amortization of debt issue costs		1,590	1,529
Loss on debt amendments		1,484
Amortization of deferred revenues, deferred lease incentives and other		(5,343)	(3,822)
Impairment of long-lived assets		591	273
Share based awards compensation expense		3,426	3,241
Loss on sale of assets and other		3,939	834
Deferred lease expenses		(483)	(347)
Equity in income of affiliates		(8,636)	(10,060)
Deferred income tax expenses		(72)	8,889
Distributions from equity investees	[1]	12,323	12,049
Changes in assets and liabilities and other		(52,378)	(64)
Net cash provided by operating activities		83,652	150,565
Investing activities
Additions to theatre properties and equipment		(80,163)	(91,187)
Proceeds from sale of theatre properties and equipment and other		477	3,835
(Investment in) return of investment from joint ventures and other, net		764	(228)
Net cash used for investing activities		(78,922)	(87,580)
Financing activities
Dividends paid to stockholders		(37,346)	(33,760)
Payroll taxes paid as a result of restricted stock withholdings		(2,695)	(2,694)
Repayments of long-term debt		(1,649)
Payment of debt issue costs		(4,962)
Fees paid related to debt amendments		(704)
Payments on capital leases		(6,090)	(4,989)
Other			(294)
Net cash used for financing activities		(53,446)	(41,737)
Effect of exchange rate changes on cash and cash equivalents		215	1,835
Increase (decrease) in cash and cash equivalents		(48,501)	23,083
Cash and cash equivalents:
Beginning of period		522,547	561,235
End of period		$ 474,046	$ 584,318

[1] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 7 and 8). These distributions are reported entirely within the U.S. operating segment.